Journal article

The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Matutes, E., Bosanquet, A., Wade, R., Richards, S., Else, M., & Catovsky, D. (2013). The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry. Leukemia, 27(2), 507–510.

MLA Style

Matutes, E, et al. “The Use of Individualized Tumor Response Testing in Treatment Selection: Second Randomization Results from the LRF CLL4 Trial and the Predictive Value of the Test at Trial Entry.” Leukemia, vol. 27, no. 2, 2013, pp. 507–10.

Chicago Style

Matutes, E, A Bosanquet, R Wade, S Richards, M Else, and D Catovsky. 2013. “The Use of Individualized Tumor Response Testing in Treatment Selection: Second Randomization Results from the LRF CLL4 Trial and the Predictive Value of the Test at Trial Entry.” Leukemia 27 (2): 507–10.
Print

Access Document

Publisher copy:: 10.1038/leu.2012.209

Authors

+ Matutes, E More by this author

Role:: Author

+ Bosanquet, A More by this author

Role:: Author

+ Wade, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

+ Richards, S More by this author

Role:: Author

+ Else, M More by this author

Role:: Author

More authors...

Journal:: Leukemia More from this journal
Volume:: 27
Issue:: 2
Pages:: 507-510
Publication date:: 2013-02-01
DOI:: 10.1038/leu.2012.209
EISSN:: 1476-5551
ISSN:: 0887-6924

Language:: English
Keywords:: Random Allocation

Randomized Controlled Trials as Topic

Neoplasm Recurrence, Local

Follow-Up Studies

Drug Resistance, Neoplasm

Prognosis

Vidarabine

Survival Rate

Humans

Drug Monitoring

Multicenter Studies as Topic

Patient Selection

Biological Assay

Antineoplastic Agents

Predictive Value of Tests

Leukemia, Lymphocytic, Chronic, B-Cell
Pubs id:: pubs:348876
UUID:: uuid:f28a2e01-5272-424a-8c87-0447345f1b8c
Local pid:: pubs:348876
Source identifiers:: 348876
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_f28a2e015272424a8c870447345f1b8c

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP